Overview

A C57BL/6J-congenic version of this strain is available as Stock No. 029661.

These knock-out mice, susceptible to infection, are useful when studying the role of C3 during immune responses.

Donating Investigator

Michael C. Carroll, The Center for Blood Research

Genetic overview

Genetic Background	Generation
	N?+pN7F23 (2019-06-12 00:00:00)

C3^tm1Crr

Allele Type	Gene Symbol	Gene Name
Targeted (Null/Knockout)	C3	complement component 3

View Genetics

Research Applications

Immunology, Inflammation and Autoimmunity Research
Developmental Biology Research
Research Tools

View All Research Applications

Base Price

Starting at:

$247.50 Domestic price for female 4-week

View Price List

Details

Detailed Description

Mice homozygous for the C3 (complement component C3) targeted mutation are viable and fertile. Homozygous mutants exhibit an increased susceptibility to lethal infection by Group B streptococci. Reductions in peritoneal mast cell degranulation, production of tumor necrosis factor alpha, neutrophil infiltration and bacterial clearance have also been reported in these mice. Homozygotes also demonstrate a profound defect in antibody response to T cell dependent antigens. They show a diminished level of peanut agglutinin+ germinal centers and a failure in isotype switching despite normal B cell signaling in vitro.

Development

The C3 gene is disrupted by PGK/Neo cassette. Approximately 600 nt of the gene are deleted. A portion of these nts (nt 1850-2214; AA 620-741, pro-C3 numbering) fall within the coding region. The targeting construct was transfected into 129S4/SvJae derived J1 ES cells. Successful transfectants were injected into 3.5 day old C57BL/6 blastocysts which were then implanted into the uterus of pseudopregnant females. Male chimeric mice were bred with C57BL/6 females. The donating investigator reported backcrossing this strain to C57BL/6J for at least five generations prior to sending to The Jackson Laboratory Repository (see SNP notes below).

A 32 SNP (single nucleotide polymorphism) panel analysis, with markers covering all 19 chromosomes and the X chromosome, was performed on the rederived living colony at The Jackson Laboratory Repository. This revealed 3 markers (representing one each on chromosomes 7, 12, and 19) that were not fixed for C57BL/6 allele-type (e.g.: still segregating for 129S4 allele-type markers). The marker on chromosome 12 may be fixed as homozygous for the 129S4 allele-type. These data suggest the mice may have been backcrossed to C57BL/6 for 1-2 fewer generations than reported prior to arrival at The Jackson Laboratory Repository.

Control Suggestions

Approximate Controls

000664 C57BL/6J

Additional Information

Considerations for Choosing Controls

Selected References

Wessels MR; Butko P; Ma M; Warren HB; Lage AL; Carroll MC. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A 92(25):11490-4PubMed: 8524789 MGI: J:30152

View All References

Genetics

C3^tm1Crr

Allele Symbol: C3^tm1Crr

Allele Name	targeted mutation 1, Michael C Carroll
Allele Type	Targeted (Null/Knockout)
Allele Synonym(s)	C^3tm1Crr; C3-; mC3^-
Gene Symbol and Name	C3, complement component 3
Gene Synonym(s)
Strain of Origin	129S4/SvJae
Chromosome	17
Molecular Note	Insertion of a PGK-neomycin resistance cassette into an exon of the C3 gene deleted sequences that code for the C-terminal region of the beta chain and the N-terminal region of the alpha chain, including the site for processing the pro-C3 molecule. ELISA testing did not detect C3 protein in serum of homozygous mutant mice. A C3 hemolytic assay did not detect functional C3 activity.
Mutations Made By	Michael Carroll, The Center for Blood Research

Disease/Phenotype

Disease Terms

Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).

complement component 3 deficiency

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: C3^tm1Crr related

Immunology, Inflammation and Autoimmunity Research
- Immunodeficiency Associated with Other Defects
- Inflammation
- Immunodeficiency
  - specific complement deficiency
Developmental Biology Research
- Lymphoid Tissue Defects
  - hematopoietic defects
Research Tools
- Immunology, Inflammation and Autoimmunity Research
  - specific complement deficiency

Research Tools
- Immunology, Inflammation and Autoimmunity Research
  - specific complement deficiency
Immunology, Inflammation and Autoimmunity Research
- Immunodeficiency
  - specific complement deficiency

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: C3^tm1Crr/C3^tm1Crr
B6.129S4-C3

behavior/neurological phenotype

abnormal spatial working memory
- age-matched 16 month old mutant mice more quickly relearn and retain new platform location than wild-type mice is reversal trial of water T maze

decreased anxiety-related response
- 16 month old mutant mice make more contacts with novel objects in first minute of test than age-matched wild-type mice
- 16 month old mutant mice make more total open arm entries than age-matched wild-type mice
- 16 month old mutant mice spend more ambulatory time in the center of the field than age-matched wild-type mice

enhanced contextual conditioning behavior
- 16 month old mutant mice exhibit increased freezing time during initial testing and 24 hours later as compared to age-matched wild-type mice
- 4 month old mutant mice exhibit increased freezing time during training, but not retention

enhanced spatial learning
- age-matched 16 month old mutant mice more quickly relearn and retain new platform location than wild-type mice is reversal trial of water T maze

growth/size/body region phenotype

decreased fetal weight
- reduced fetus/placenta ratio
- significantly reduced fetal weight

hematopoietic system phenotype

abnormal neutrophil morphology
- neutrophils that accumulate at the site of a local Shwartman response are round instead of flattened as in wild-type mice

decreased susceptibility to autoimmune hemolytic anemia
- mice are resistant to hemolytic anemia induced by self-binding IgG2a antibodies
- no protection is seen with pathogenic IgM or IgA self-antibodies

homeostasis/metabolism phenotype

abnormal blood homeostasis
- mouse serum fails to support neutrophil adhesion unlike serum from wild-type mice

decreased cerebral infarction size
- significantly reduced infarct volume but mortality unaffected

immune system phenotype

abnormal inflammatory response
- following exposure to LPS then challenge with TNF at the same site to initiate a local Shwartman response, mice fail to exhibit hemorrhage and exhibit reduced fibrin deposition compared to the thrombohemorrhagic vasculitis observed in wild-type mice despite normal neutrophil accumulation
- te normal neutrophil accumulation

abnormal neutrophil morphology
- neutrophils that accumulate at the site of a local Shwartman response are round instead of flattened as in wild-type mice

brain inflammation
- reduced granulocyte infiltration of infarct sites

decreased susceptibility to autoimmune hemolytic anemia
- mice are resistant to hemolytic anemia induced by self-binding IgG2a antibodies
- no protection is seen with pathogenic IgM or IgA self-antibodies

nervous system phenotype

abnormal dendritic spine morphology
- increased dendritic spine density is observed in the hippocampal CA3 region of 16 month old mice as compared to wild-type

abnormal hippocampus CA3 region morphology
- mutant mice do not exhibit age-dependent neuron loss in the hippocampal CA3 region from P30 to 16 months

abnormal synaptic plasticity
- synaptic plasticity is improved as compared to age matched 12 month old wild-type mice

abnormal synaptic vesicle number
- protective effects (to a lesser extent) against synapse loss are also observed in hippocampal DG and V1 regions, but not in the CA1 region, at 16 months of age
- synaptic puncta density in the hippocampal CA3 region is higher in mutant males than in wild-type males at 4 months of age; density is similar to wild-type at P30

brain inflammation
- reduced granulocyte infiltration of infarct sites

decreased cerebral infarction size
- significantly reduced infarct volume but mortality unaffected

enhanced long term potentiation
- observed in 12 month old mice as compared to age-matched wild-type

enhanced paired-pulse facilitation
- observed in 12 month old mice as compared to age-matched wild-type

increased neuron number
- mutant mice do not exhibit age-dependent neuron loss in the hippocampal CA3 region from P30 to 16 months
- neuron numbers in CA1, V1 cortex and cerebellum are similar to wild-type

reproductive system phenotype

abnormal female reproductive system physiology

impaired embryo implantation
- insignificantly but consistently reduced level of implantation at day 8

prolonged estrous cycle
- 5.42 days vs 4.41 days in controls

embryo phenotype

abnormal blastocyst morphology
- blastocyst count at 4 days is consistently but insignificantly lower than in controls

decreased placental labyrinth size
- labyrinth area significantly reduced at day 15 of pregnancy

decreased spongiotrophoblast size
- significantly reduced spongioblast at day 15 of pregnancy

small placenta
- reduced placenta area at day 15 of pregnancy

Genotype: C3^tm1Crr/C3^tm1Crr
involves: 129S4/SvJae

homeostasis/metabolism phenotype

abnormal blood coagulation
- thrombus formation considerably reduced

decreased susceptibility to injury
- following exposure to ethanol, mice do not develop microvesicular or macrovesicular steatosis of the liver and do not accumulate excessive trglycerides as in wild-type mice
- following exposure to ethanol, mice exhibit a reduced increased in alanine aminotransferase compared to in similarly treated wild-type mice

decreased urine albumin level
- albuminuria 1/50 control levels after 0.5ng dose of anti glomerular basement membrane antiserum and 1/13 of control levels after 1 ng of antiserum

immune system phenotype

glomerulonephritis
- reduced neutrophil infiltration of glomerulus relative to controls when injected with 0.5 mg but not with 1.0mg of anti-glomerular basement membrane antiserum

liver/biliary system phenotype

decreased susceptibility to hepatic steatosis
- following exposure to ethanol, mice do not develop microvesicular or macrovesicular steatosis of the liver as in wild-type mice

renal/urinary system phenotype

decreased urine albumin level
- albuminuria 1/50 control levels after 0.5ng dose of anti glomerular basement membrane antiserum and 1/13 of control levels after 1 ng of antiserum

glomerulonephritis
- reduced neutrophil infiltration of glomerulus relative to controls when injected with 0.5 mg but not with 1.0mg of anti-glomerular basement membrane antiserum

The following phenotype relates to a compound genotype created using this strain

Genotype: C3^tm1Crr/C3^tm1Crr
involves: 129S4/SvJae * C57BL/6

cardiovascular system phenotype

decreased vascular permeability
- upeon reperfusion of ischemic intestine (jejunum), permeability index (PI) of injured C3-deficient mice is reduced compared to control treated wild-type (PI of 2.25 vs 3.26 in controls)

homeostasis/metabolism phenotype

abnormal enzyme/coenzyme level
- lower levels of myeloperoxidase in livers at 6 and 24 hours of reperfusion

abnormal tumor necrosis factor level
- levels of Tnfa in peritoneal lavage fluids are reduced in C3-deficient mice compared to controls at 1 hour (158 mg/pl vs 400 mg/pl) and 3 hours (218 mg/pl vs 663 pg/ml) after CLP
- treatment with HuC3 restores levels of Tnfa production in mutants to wild-type levels

decreased circulating alanine transaminase level
- levels lower during reperfusion after ischemia than in controls

decreased circulating interleukin-6 level
- Il-6 production after vitamin D3 stimulation is significantly reduced
- reduced levels at 6 and 24 hours after 6 and 24 hours of reperfusion

decreased circulating tumor necrosis factor level
- reduced TNFalpha levels at 6 and 24 hours after 6 and 24 hours of reperfusion

decreased susceptibility to injury
- mice are resistant to ischemia reperfusion-induced renal injury
- neutrophil infiltration at the site of injury was reduced
- serum urea nitrogen is reduced 31% to 55% compared to wild-type mice subjected to ischemia reperfusion

increased circulating alanine transaminase level
- after 70% partial hepatectomy

increased circulating bilirubin level
- after 70% partial hepatectomy

cellular phenotype

decreased hepatocyte proliferation
- impaired hepatocyte proliferation after 30 minutes of ischemia during 70% partial hepatectomy

focal hepatic necrosis
- after 70% partial hepatectomy

immune system phenotype

abnormal cell-mediated immunity
- in an in vitro assay, opsonization with serum from C3-deficient mice and 1% immune rabbit serum only resulted in a 0.2 log10 reduction in GBS CFU compared to a 1.0 log10 reduction by normal mouse serum

abnormal humoral immune response
- in response to immunization with bacteriophage (phiX174), a T cell dependent antigen, C3-deficient mice mount a weak Ig M response but fail to switch to IgG
- when immunized with a 10-fold higher amount of bacteriophage, mice show a weak IgG response but response is still 10-fold lower than wild-type

abnormal immune system morphology

abnormal immune system physiology

abnormal mast cell physiology
- mast cells from mutants 1 or 3 hours after CLP show reduced degranulation compared to wild-type (75% of wild-type cells vs <50% of C3-deficient cells)
- treatment with HuC3 results in comparable levels of mast cell degranulation to wild-type

abnormal spleen germinal center morphology

abnormal tumor necrosis factor level
- levels of Tnfa in peritoneal lavage fluids are reduced in C3-deficient mice compared to controls at 1 hour (158 mg/pl vs 400 mg/pl) and 3 hours (218 mg/pl vs 663 pg/ml) after CLP
- treatment with HuC3 restores levels of Tnfa production in mutants to wild-type levels

decreased circulating interleukin-6 level
- Il-6 production after vitamin D3 stimulation is significantly reduced
- reduced levels at 6 and 24 hours after 6 and 24 hours of reperfusion

decreased circulating tumor necrosis factor level
- reduced TNFalpha levels at 6 and 24 hours after 6 and 24 hours of reperfusion

decreased mast cell number
- after CLP less peritoneal mast cells can be recovered from Cr3-deficient mice compared to controls

decreased neutrophil cell number
- 1 hour after CLP, 50% of peritoneal cells are neutrophils and after 3 hours, 90% are neutrophils while in C3-deficient mice, after 1 hour only 1% and 45% after 3 hours are neutrophils

decreased osteoclast cell number
- bone marrow cells incubated with 1,25(OH)2 vitamin D3 produce fewer osteoclasts than do cells from controls

decreased spleen germinal center number
- after immunization, wild-type mice develop germinal centers (GC) in ~half of splenic follicles while ~10% of splenic follicles in C3-deficient mice contain GCs

decreased spleen germinal center size
- diameter of GCs are less than that observed in wild-type

increased susceptibility to bacterial infection
- at 1 or 3 hours after CLP, cytocentrifuge preparations or peritoneal fluid from C3-deficient mice have reduced neutrophil counts and large numbers of bacteria, compared to wild-type which have few or no bacteria
- increased mortality from GBS infection compared to controls is limited to the first 3 days after challenge
- LD₅₀ dose: control 6.3 x 10⁴ vs. 1.3 x 10³ in C3-deficient mice)
- mice challenged with group B Streptococci (GBS) infection become bacteremic within 3 days and die or clear bacteria and survive; C3-deficient mice challenged with GBS infection showed a decreased LD₅₀ dose compared to immunocompetent controls (LD₅₀ dose: control 6.3 x 10⁴ vs. 1.3 x 10³ in C3-deficient mice)
- treatment with HuC3 restore neutrophil numbers and enhance bacterial clearance to wild-type levels
- when pregnant dams are immunized with immune rabbit serum, pups are not protected against lethal challenge on day 2 of life (15/20 pups die within 48 hours)

increased susceptibility to bacterial infection induced morbidity/mortality
- in mice infected with S. pneumoniae

liver inflammation
- mild hepatitis is observed in a small number (1/11) of mice surviving systemic challenge with GBS doses of 10² to 10⁵ CFU upon necropsy 15 days post-challenge; there are aggregates of mononuclear or polymorphonuclear leukocytes in hepatic sinusoids; wild-type animals that receive higher doses of GBS showed similar lesions
- patic sinusoids; wild-type animals that receive higher doses of GBS showed similar lesions

digestive/alimentary phenotype

abnormal intestine morphology
- mice show less evidence of infarction compared to controls

hematopoietic system phenotype

abnormal mast cell physiology
- mast cells from mutants 1 or 3 hours after CLP show reduced degranulation compared to wild-type (75% of wild-type cells vs <50% of C3-deficient cells)
- treatment with HuC3 results in comparable levels of mast cell degranulation to wild-type

abnormal spleen germinal center morphology

decreased mast cell number
- after CLP less peritoneal mast cells can be recovered from Cr3-deficient mice compared to controls

decreased neutrophil cell number
- 1 hour after CLP, 50% of peritoneal cells are neutrophils and after 3 hours, 90% are neutrophils while in C3-deficient mice, after 1 hour only 1% and 45% after 3 hours are neutrophils

decreased osteoclast cell number
- bone marrow cells incubated with 1,25(OH)2 vitamin D3 produce fewer osteoclasts than do cells from controls

decreased spleen germinal center number
- after immunization, wild-type mice develop germinal centers (GC) in ~half of splenic follicles while ~10% of splenic follicles in C3-deficient mice contain GCs

decreased spleen germinal center size
- diameter of GCs are less than that observed in wild-type

liver/biliary system phenotype

abnormal liver morphology
- histological evidence of injury after 6 and 24 hours of reperfusion following ischemia

abnormal liver physiology

decreased hepatocyte proliferation
- impaired hepatocyte proliferation after 30 minutes of ischemia during 70% partial hepatectomy

decreased liver regeneration
- impaired regenerative response after 70% hepatectomy
- significant hepatic injury after 30 minutes of ischemia during 70% partial hepatectomy

focal hepatic necrosis
- after 70% partial hepatectomy

hepatic steatosis
- increased steatosis after 70% hepatectomy

liver inflammation
- mild hepatitis is observed in a small number (1/11) of mice surviving systemic challenge with GBS doses of 10² to 10⁵ CFU upon necropsy 15 days post-challenge; there are aggregates of mononuclear or polymorphonuclear leukocytes in hepatic sinusoids; wild-type animals that receive higher doses of GBS showed similar lesions
- patic sinusoids; wild-type animals that receive higher doses of GBS showed similar lesions

mammalian phenotype

immune system phenotype
- Normal - B cells from deficient mice show normal proliferative effects in response to surface IgM crosslinking
- secondary immune responses are similar in wild type and mutant mice, so helper T cell function is normal
- Normal - secondary immune responses are similar in wild-type and mutant mice, so helper T cell function is normal

mortality/aging

abnormal induced morbidity/mortality
- poor survival (20%) after 30 minutes of ischemia while 70% partial hepatectomy performed

increased sensitivity to induced morbidity/mortality
- caecal ligation and puncture (CLP) causes greater mortality in mutants than wild-type in the first 24 hours after CLP (100 vs 20% mortality)
- reconstitution of mice with ip. injection of purified human C3 (HuC3) reduces mortality from 100% to 40% in the first 24 hours

increased susceptibility to bacterial infection induced morbidity/mortality
- in mice infected with S. pneumoniae

nervous system phenotype

abnormal peripheral nervous system regeneration
- grossly normal at 7 days after injury compared to controls which show marked necrosis and vacuolation in controls at 21 days
- locomotor recovery from spinal cord injury occurs more rapidly than in controls
- slight improvement in tissue at 24 hours aftwr injury but considerably improved relative to controls by 72 hours

skeleton phenotype

decreased osteoclast cell number
- bone marrow cells incubated with 1,25(OH)2 vitamin D3 produce fewer osteoclasts than do cells from controls

Genotype: C3^tm1Crr/C3^tm1Crr
B6;129S4-C3/J

homeostasis/metabolism phenotype

decreased circulating free fatty acid level
- plasma free polyunsaturdated fatty acid (linoleic acid and arachidonic acid) levels are decreased at 14 months of age

immune system phenotype

decreased susceptibility to Coronaviridae infection
- Normal - however, SARS-CoV MA15-infected mice show similar levels of viral titers in the lung and ratio of peak expiratory flow as in controls
- mice show partial protection from intranasal infection with the mouse-adapted SARS-CoV MA15 compared to wild-type controls, showing no significant weight loss, decreased airway resistance associated with airway debris and exhalation force indicating improved respiratory function, reduced lung pathology, reductions in inflammatory monocytes and neutrophils and increases in dendritic cells and alveolar macrophages in the lungs by day 4 postinfection, and reduction in cytokine and chemokine responses in the lungs
- SARS-CoV MA15-infected mice exhibit more airspace inflammation at day 2 postinfection than controls but his is reversed later in infection

increased susceptibility to bacterial infection
- Normal - mice infected with 500 CFU of S. aureus, show higher numbers of bacterial SFU (intraocular growth) at 24 and 48 hours post-infection, levels are indistinguishable from infected wild-type by 72 hours

mammalian phenotype

vision/eye phenotype
- Normal - eyes infected with 500 CFU S. aureus show mild signs of inflammation at 24 and 48 hours but appear normal at 72 hours

nervous system phenotype

abnormal horizontal cell morphology
- density of horizontal cells is decreased

abnormal retinal rod bipolar cell morphology
- the number of rod bipolar cells is decreased at 14 months of age

vision/eye phenotype

abnormal c wave shape
- Normal - however, no other component of the dc-ERG is different
- the amplitude of the c-wave is reduced at 12 months of age, but not at 8 weeks of age

abnormal eye electrophysiology
- 24 hours after infection with 500 CFU of S. aureus, mice show a transient loss of b-wave amplitude; this stabilizes at a level of 66% of baseline values, similar to what is seen in eyes of infected wild-type mice

abnormal horizontal cell morphology
- density of horizontal cells is decreased

abnormal retinal rod bipolar cell morphology
- the number of rod bipolar cells is decreased at 14 months of age

decreased b wave amplitude
- ERG b-waves are decreased at 12 months of age but not at younger ages

References

Wessels MR; Butko P; Ma M; Warren HB; Lage AL; Carroll MC. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A 92(25):11490-4PubMed: 8524789 MGI: J:30152

Additional References

Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD. 2003. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res 63(24):9023-31PubMed: 14695221 MGI: J:87069
Shi Q; Colodner KJ; Matousek SB; Merry K; Hong S; Kenison JE; Frost JL; Le KX; Li S; Dodart JC; Caldarone BJ; Stevens B; Lemere CA. 2015. Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J Neurosci 35(38):13029-42PubMed: 26400934 MGI: J:224676
Sun D; Sun P; Li H; Zhang M; Liu G; Strickland AB; Chen Y; Fu Y; Xu J; Yosri M; Nan Y; Zhou H; Zhang X; Shi M. 2019. Fungal dissemination is limited by liver macrophage filtration of the blood. Nat Commun 10(1):4566PubMed: 31594939 MGI: J:281372
Tuzun E; Scott BG; Goluszko E; Higgs S; Christadoss P. 2003. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol 171(7):3847-54PubMed: 14500686 MGI: J:85645
Yamada K; Miwa T; Liu J; Nangaku M; Song WC. 2004. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172(6):3869-75PubMed: 15004194 MGI: J:88632

Additional - C3^tm1Crr related

Technical Support

CONTACT TECHNICAL SUPPORT

Genotyping Protocols
- Standard PCR:C3
- Genotyping resources and troubleshooting
Dietary Information
- LabDiet® 5K52 formulation (6% fat)
Breeding Considerations

When maintaining a live colony, homozygous mice may be bred together. The expected coat color from breeding is black.
- Additional Breeding and Husbandry Support
Mating System
- Homozygote x Homozygote
Citation
When using the B6;129S4-C3^tm1Crr/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #003641 in your Materials and Methods section.

Animal Health Reports

Facility Barrier Level Descriptions

AX11 (Maximum)

Pricing & Availability

Available

Domestic
International

Live Mouse

Age

Genotype

Price

weeks

Cryorecovery - Pricing

Service/Product	Description	Price
	Heterozygous or Wild-type for C3<tm1Crr>

Related Products and Services

Frozen Mouse Embryo	B6;129S4-C3<tm1Crr>/J Frozen Embryos	$2595.00
Frozen Mouse Embryo	B6;129S4-C3<tm1Crr>/J Frozen Embryos	$2595.00
Frozen Mouse Embryo	B6;129S4-C3<tm1Crr>/J Frozen Embryos	$3373.50
Frozen Mouse Embryo	B6;129S4-C3<tm1Crr>/J Frozen Embryos	$3373.50

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.

Terms Of Use

General Terms and Conditions

Questions about Terms of Use

Additional Use Restrictions Apply

Use of MICE by companies or for-profit entities requires a license prior to shipping.

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Approximate Controls

Additional Information

Selected References

C3tm1Crr

Allele Symbol: C3tm1Crr

Disease Terms

Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: C3tm1Crr related

Mammalian Phenotype Terms by Genotype

Genotype: C3tm1Crr/C3tm1CrrB6.129S4-C3

behavior/neurological phenotype

growth/size/body region phenotype

hematopoietic system phenotype

homeostasis/metabolism phenotype

immune system phenotype

nervous system phenotype

reproductive system phenotype

embryo phenotype

Genotype: C3tm1Crr/C3tm1Crrinvolves: 129S4/SvJae

homeostasis/metabolism phenotype

immune system phenotype

liver/biliary system phenotype

renal/urinary system phenotype

Genotype: C3tm1Crr/C3tm1Crrinvolves: 129S4/SvJae * C57BL/6

cardiovascular system phenotype

homeostasis/metabolism phenotype

cellular phenotype

immune system phenotype

digestive/alimentary phenotype

hematopoietic system phenotype

liver/biliary system phenotype

mammalian phenotype

mortality/aging

nervous system phenotype

skeleton phenotype

Genotype: C3tm1Crr/C3tm1CrrB6;129S4-C3/J

homeostasis/metabolism phenotype

immune system phenotype

mammalian phenotype

nervous system phenotype

vision/eye phenotype

References

Additional References

Additional - C3tm1Crr related

Genotyping Protocols

Dietary Information

Breeding Considerations

Mating System

Citation

Animal Health Reports

Live Mouse

Cryorecovery - Pricing

Related Products and Services

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms Of Use

Additional Use Restrictions Apply

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

C3^tm1Crr

Allele Symbol: C3^tm1Crr

Genotype: C3^tm1Crr related

Genotype: C3^tm1Crr/C3^tm1Crr
B6.129S4-C3

Genotype: C3^tm1Crr/C3^tm1Crr
involves: 129S4/SvJae

Genotype: C3^tm1Crr/C3^tm1Crr
involves: 129S4/SvJae * C57BL/6

Genotype: C3^tm1Crr/C3^tm1Crr
B6;129S4-C3/J

Additional - C3^tm1Crr related